Evidence of persistent low-level viremia in long-term HAART-suppressed, HIV-infected individuals (Q34195386)

31 July 2017

title

Evidence of persistent low-level viremia in long-term HAART-suppressed, HIV-infected individuals (English)

1 reference

31 July 2017

1 reference

31 July 2017

Steven G Deeks

1 reference

31 July 2017

Michael P Busch

1 reference

31 July 2017

Tzong-Hae Lee

1 reference

31 July 2017

Torsten B Neilands

1 reference

31 July 2017

Hiroyu Hatano

1 reference

31 July 2017

Rebecca Hoh

1 reference

31 July 2017

Jeffrey M Linnen

1 reference

31 July 2017

Philip J Norris

1 reference

31 July 2017

Colleen F Kelley

series ordinal

1 reference

31 July 2017

Peter W Hunt

series ordinal

1 reference

31 July 2017

Jeffrey N Martin

series ordinal

1 reference

31 July 2017

language of work or name

English

0 references

publication date

1 October 2010

1 reference

31 July 2017

1 reference

31 July 2017

1 reference

31 July 2017

1 reference

31 July 2017

page(s)

2535-2539

1 reference

HIV-1 residual viremia correlates with persistent T-cell activation in poor immunological responders to combination antiretroviral therapy.

31 July 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2954261

Treatment intensification does not reduce residual HIV-1 viremia in patients on highly active antiretroviral therapy

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2954261

Evidence for persistent low-level viremia in individuals who control human immunodeficiency virus in the absence of antiretroviral therapy

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2954261

Inflammatory and coagulation biomarkers and mortality in patients with HIV infection

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2954261

Low-level viremia persists for at least 7 years in patients on suppressive antiretroviral therapy

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2954261

ART suppresses plasma HIV-1 RNA to a stable set point predicted by pretherapy viremia

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2954261

CD4+ count-guided interruption of antiretroviral treatment

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2954261

Residual human immunodeficiency virus type 1 viremia in some patients on antiretroviral therapy is dominated by a small number of invariant clones rarely found in circulating CD4+ T cells

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2954261

Productive infection maintains a dynamic steady state of residual viremia in human immunodeficiency virus type 1-infected persons treated with suppressive antiretroviral therapy for five years

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2954261

New testing strategy to detect early HIV-1 infection for use in incidence estimates and for clinical and prevention purposes

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2954261

HIV-1 replication and immune dynamics are affected by raltegravir intensification of HAART-suppressed subjects.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2954261

Less sensitive HIV-1 enzyme immunoassay as an adjuvant method for monitoring patients receiving antiretroviral therapy.

28 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2954261

Seroreversion in subjects receiving antiretroviral therapy during acute/early HIV infection

28 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2954261

Intermittent HIV-1 viremia (Blips) and drug resistance in patients receiving HAART.

28 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2954261

Detection of HIV-1 and HCV infections among antibody-negative blood donors by nucleic acid-amplification testing

28 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2954261

Sensitivity of HCV RNA and HIV RNA blood screening assays

28 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2954261

Nucleic acid amplification testing for diagnosis of acute HIV infection: has the time come?

28 October 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/20651585

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Targeted screening for primary HIV infection through pooled HIV-RNA testing in men who have sex with men

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/20651585

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1097/QAD.0B013E32833DBA03

1 reference

31 July 2017

1 reference

31 July 2017

1 reference